13F HOLDINGS REPORT
CAXTON CORP
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0000919574-23-006304
Total Value
$26.3M
Positions
9
Other Managers
0
Confidential Omitted
Yes
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SAVARA INC | SVRA | 3,313,602 | $12.5M | 47.59% |
| 2 | XERIS BIOPHARMA HOLDINGS INC | XERS | 5,641,920 | $10.5M | 39.87% |
| 3 | REZOLUTE INC | RZLT | 1,318,967 | $1.7M | 6.61% |
| 4 | MOLECULAR TEMPLATES INC | 608550208 | 136,866 | $864,993 | 3.29% |
| 5 | APOGEE THERAPEUTICS INC | APGE | 12,472 | $265,653 | 1.01% |
| 6 | COMPASS THERAPEUTICS INC | CMPX | 86,773 | $170,942 | 0.65% |
| 7 | ACLARIS THERAPEUTICS INC | ACRS | 19,473 | $133,387 | 0.51% |
| 8 | ALLAKOS INC | 01671P100 | 49,329 | $111,978 | 0.43% |
| 9 | ELEVATION ONCOLOGY INC | 28623U101 | 21,813 | $14,453 | 0.05% |